Mast cells protect against airway Mycoplasma pneumoniae under allergic conditions

N M Michels1, H W Chu, S C LaFasto

  • 1National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA.

Abstract

Insights

Mast cells help clear Mycoplasma pneumoniae (Mp) infections in allergic asthma by aiding host defense. However, mast cell-derived IL-6 is not essential for this lung Mp clearance.

Area of Science:

  • Immunology
  • Respiratory Medicine
  • Microbiology

Background:

  • Asthma is linked to Mycoplasma pneumoniae (Mp) infection, Th2 inflammation, and increased mast cells.
  • Mast cells promote mycoplasma clearance in mice, but their role in allergic conditions is unclear.

Purpose of the Study:

  • To investigate how allergic inflammation affects mast cell-mediated lung Mp clearance.
  • To determine the role of mast cell-derived IL-6 in lung Mp clearance.

Main Methods:

  • Mast cell-deficient mice were sensitized to ovalbumin to induce allergic airway inflammation before Mp infection.
  • Reconstitution of mast cell-deficient mice with wild-type or IL-6(-/-) mast cells was performed to assess IL-6's role.

Main Results:

  • Allergic mast cell-deficient mice showed higher lung Mp burden.
  • Adoptive transfer of mast cells improved Mp clearance.
  • Allergen-challenged mast cell-deficient mice had elevated IL-6, TNF-alpha, and neutrophils in BAL fluid.

Conclusions:

  • Mast cells contribute to host defense against Mp during allergic inflammation.
  • IL-6 is crucial for lung Mp clearance, but mast cell-derived IL-6 is not required.

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Inflammation01:38

Inflammation

Overview